Endometrial Neoplasms Clinical Trial
— DEUSOfficial title:
Randomised, Controlled, Pilot Clinical Trial to Assess the Feasibility of a Healthy Eating and Physical Activity Program in Endometrial Cancer Survivors
NCT number | NCT02433080 |
Other study ID # | 14/0765 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | April 2015 |
Est. completion date | June 2016 |
Verified date | May 2020 |
Source | University College, London |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Endometrial cancer is the most common gynaecological cancer in developed countries with more
than 75% of the patients surviving for at least five years. However, most endometrial cancer
survivors are overweight and obese and do not meet the current nutrition and physical
activity recommendations. This can lower their quality of life and increase their risk for
chronic diseases. Behaviour change interventions can help them feel better about themselves
and improve their quality of life. Applying them shortly after treatment seems ideal as
cancer survivors feel motivated to make changes about their lifestyle at this time point.
This study is to see if the investigators can design a project to measure how well a
psycho-educational healthy eating and physical activity programme tailored to the survivors'
needs works. Sixty-four endometrial cancer survivors diagnosed during the previous three
years, and are all clear will be put by chance into one of two groups. One will receive the
program. The other will receive usual care until the end of the trial and, then, a discussion
and a self-help guide about eating well and being active following cancer treatment. This
will help us to see if the programme makes a difference compared with usual care. The results
will inform a larger study to test if a lifestyle program can improve the quality of life of
uterine cancer survivors compared with usual care. The investigators will change the
programme materials in response to the investigators' findings, making them available to
services. The results will inform practice and research.
Status | Completed |
Enrollment | 60 |
Est. completion date | June 2016 |
Est. primary completion date | December 2015 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: 1. Women aged >18 years (no upper age limit) 2. Women diagnosed with endometrial cancer (C54.1) within the previous 36 months 3. Women who are able to understand spoken and written English Exclusion Criteria: 1. Women with stage IVB (metastatic) endometrial cancer (any metastasis beyond the pelvis) 2. Women on active anti-cancer, and/or palliative treatment, 3. Women having second primary cancer 4. Women who lack mental capacity to decide to take part in the study and to participate in it (upon clinical team's judgement in accordance with the Mental Capacity Act 2005 Code of Practice 2007) 5. Women with severe depression (upon consultant's judgement based on the Diagnostic and Statistical Manual of Mental Disorders-IV criteria) 6. Women unavailable for longitudinal follow-up assessments 7. Women who participated in a professionally delivered weight loss or exercise program during the previous 6 months 8. Women with a World Health Organization performance score 3-4 |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Barts Health NHS Trust | London | Greater London |
United Kingdom | University College London Hospital NHS Trust | London | Greater London |
Lead Sponsor | Collaborator |
---|---|
University College, London |
United Kingdom,
Chiuve SE, Fung TT, Rimm EB, Hu FB, McCullough ML, Wang M, Stampfer MJ, Willett WC. Alternative dietary indices both strongly predict risk of chronic disease. J Nutr. 2012 Jun;142(6):1009-18. doi: 10.3945/jn.111.157222. Epub 2012 Apr 18. — View Citation
Koutoukidis DA, Lopes S, Atkins L, Croker H, Knobf MT, Lanceley A, Beeken RJ. Use of intervention mapping to adapt a health behavior change intervention for endometrial cancer survivors: the shape-up following cancer treatment program. BMC Public Health. 2018 Mar 27;18(1):415. doi: 10.1186/s12889-018-5329-5. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Recruitment Rate (Percentage of Potentially Eligible Participants Who Were Enrolled to the Study) | Achieving a 30% recruitment rate of the potentially eligible participants | 6 months | |
Secondary | Change From Baseline in Health-related Quality of Life Score | European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 & European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module 24 Global quality of life scale ranging from 0-100 with higher scores indicating better quality of life | Baseline, 8weeks, 24weeks | |
Secondary | Change From Baseline in Dietary Quality (24-h Dietary Recall) | One 24-h dietary recall for each timepoint. This is the combined total Alternate healthy eating index-2010 score ranging from 0-110 with higher scores indicating higher dietary quality. | Baseline, 8weeks, 24weeks | |
Secondary | Change From Baseline in Physical Activity (Physical Activity Recall) | 7-day physical activity recall | Baseline, 8weeks, 24weeks | |
Secondary | Change From Baseline in Hand-grip Strength | Baseline, 8weeks, 24weeks | ||
Secondary | Change From Baseline in Weight | Baseline, 8weeks, 24weeks | ||
Secondary | Change From Baseline in Fat Mass Index | Using MC980 multi-frequency segmental body composition analyser. Fat mass index was calculated as kg of fat mass divided by squared height in meters. | Baseline, 8weeks, 24weeks | |
Secondary | Intervention Evaluation Questionnaire | Change in the self-assessment of the gained skills (Shape-Up self-efficacy score). This is a total score 0-5 with higher scores indicating higher self-efficacy. | 8weeks, 24weeks | |
Secondary | Health Care Services Use - Medication | Number of currently prescribed medications over the 24 weeks of the trial (Self-reported) | 24weeks | |
Secondary | Adherence Rate | The percentage of engaged participants attending at least one of the last three sessions of the intervention. Engaged participants are those who have attended at least two sessions of the intervention. | 8 weeks | |
Secondary | Retention Rate | Rate of complete follow-up | Baseline to 24weeks | |
Secondary | Health Care Services Use - Number of General Practitioner Visits | Number of visits to their general practitioner over the 24 weeks of the trial (Self-reported) | 24weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT06409039 -
POLE-END REAL LIFE: Endometrial Cancer Early Stages I-II and Advanced Stages III and IV Evaluation of POLE as a Prognostic Factor. Participants Are Women >= 18 Years Old, With the Pole Mutation
|
||
Completed |
NCT02865889 -
Cost-Effectiveness and Patients Satisfaction of Conventional vs Robotic-Assisted Laparoscopy in Gynecologic Oncologic Indications
|
N/A | |
Completed |
NCT00377520 -
A Trial for Patients With Advanced/Recurrent Endometrial Cancer
|
Phase 2 | |
Recruiting |
NCT05007106 -
MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)
|
Phase 2 | |
Recruiting |
NCT05001282 -
A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT05682950 -
Optimal Margin Evaluation of Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer
|
Phase 2 | |
Not yet recruiting |
NCT05974995 -
Robotic-assisted Versus Conventional Laparoscopic Surgery in Obese Patients With Early Endometrial Cancer
|
N/A | |
Recruiting |
NCT03291106 -
Study of Universal Screening for Lynch Syndrome in Chinese Patients of Endometrial Cancer
|
||
Recruiting |
NCT03291275 -
Survival Outcomes of Uterine Malignancies in Chinese Population
|
N/A | |
Completed |
NCT00341458 -
Breast Cancer in Poland: An Expanded Study to Assess Occupational and Environmental Factors and Interactions With Genetics
|
||
Terminated |
NCT05067972 -
A Study of PF-07260437 in Advanced or Metastatic Solid Tumors
|
Phase 1 | |
Recruiting |
NCT05795244 -
Study of Induction PD-1 Blockade (Nivolumab) in Patients With Surgically Complete Resectable Mismatch Repair Deficient Endometrial Cancer (NIVEC)
|
Phase 2 | |
Recruiting |
NCT05770102 -
DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Teenage/Young Adults and Paediatric Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT04865289 -
Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001) - China Extension Study
|
Phase 3 | |
Completed |
NCT03270995 -
Cognitive-Existential Group Therapy to Reduce Fear of Cancer Recurrence: A RCT Study
|
N/A | |
Terminated |
NCT01969396 -
Evaluation of the Goldstein SonoBiopsy™ Catheter for Diagnosing Endometrial Pathology
|
N/A | |
Completed |
NCT01460979 -
Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced Endometrial Carcinoma
|
Phase 2 | |
Active, not recruiting |
NCT05869123 -
Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer
|
Phase 1/Phase 2 | |
Terminated |
NCT02900248 -
CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
|
||
Active, not recruiting |
NCT05588076 -
Endometrial Lesions Predictions
|